As CKD–MBD is not a single disease entity but encompasses a variety of altered mineral and bone metabolisms, a patient is initially evaluated for CKD–MBD by measuring serum calcium, phosphate, and PTH levels, and examining ectopic calcification with lateral abdominal radiography and echocardiography. Here, PTH is linked to chronic kidney disease.